Harmonica Playing Improves Quality of Life in Patients With COPD
Harmonica Playing Improves Inspiratory and Expiratory Muscle Strength, Reduces Shortness of Breath With Activity, and Improves Quality of Life in Patients With COPD
1 other identifier
interventional
15
1 country
1
Brief Summary
15 patients who have completed the Baylor Martha Foster Lung Center Pulmonary Rehabilitation Program at least six months ago will be selected to participate in a 12 week training program with six months of follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 8, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedJanuary 30, 2026
January 1, 2026
7 months
February 8, 2018
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in Shortness of Breath
Change 6-minute walk test and spirometry from baseline to 12 weeks and 6 months.
6 months
Secondary Outcomes (1)
saint George Quality of Life
6 months
Study Arms (1)
Experimental
EXPERIMENTALPatients who completed the Baylor Martha Foster Lung Center Pulmonary Rehabilitation Program at least six months ago will participate in the 12-week harmonica program
Interventions
Eligibility Criteria
You may qualify if:
- Willingness to attend 12 weeks of harmonica training for one hour a day per week
- Practice playing at home 30 minutes x 5 days a week
- Documented diagnosis of COPD
- Ability to perform spirometry, IC, MIP, and MEP maneuver and 6 minute walk
- Willing to complete depression, quality of life, shortness of breath, functional evaluation questionnaires
- Willing to perform in a group setting
You may not qualify if:
- Current COPD exacerbation
- Inability to perform spirometry, IC, MIP and MEP maneuver
- Inability to commit to weekly one hour sessions for 12 weeks and practice for 5 days/week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor University Medical Center
Dallas, Texas, 75246, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Millard
Baylor Health Care System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2018
First Posted
February 22, 2018
Study Start
August 1, 2017
Primary Completion
March 1, 2018
Study Completion
December 1, 2019
Last Updated
January 30, 2026
Record last verified: 2026-01